Specialty Research
PT-141
Positioned carefully for research use only, with supporting documentation cues and no consumer claims.
products are for qualified laboratory research use only. Not for human or veterinary use.
Mechanism of action
PT-141 (Bremelanotide) is a synthetic melanocortin agonist acting primarily at MC3R and MC4R. Research focuses on central melanocortin system signalling in hypothalamic circuits, examining downstream dopamine release, autonomic nervous system modulation, and nociception pathway interactions.
Specifications
- Format
- Lyophilized vial
- Size
- 10mg
- Purity
- 98%+ target
- Status
- available
- Storage
- Store lyophilized at −20 °C. Reconstituted solution: 4 °C, use within 14 days. Sensitive to oxidation.
- Solubility
- Soluble in sterile water at 1–5 mg/mL. May require brief sonication for complete dissolution.
Documentation cues
Every lot is batch-tested by an accredited third-party laboratory before release. Certificate of Analysis includes HPLC purity trace, mass spectrometry identity confirmation, and endotoxin result.
View quality architecture →You may also need
Frequently ordered together
